166 related articles for article (PubMed ID: 35259485)
1. Comparing outcomes among outpatients treated for pyelonephritis with oral cephalosporins versus first-line agents.
Fosse PE; Brinkman KM; Brink HM; Conner CE; Aden JK; Giancola SE
Int J Antimicrob Agents; 2022 Apr; 59(4):106560. PubMed ID: 35259485
[TBL] [Abstract][Full Text] [Related]
2. Assessment of nationally recommended antibiotics for treatment of UTI in U.S.-Mexico border emergency departments.
Davis WH; Magee MR; Monks SM; Geno KA; Crawford SB
Am J Emerg Med; 2022 Nov; 61():12-17. PubMed ID: 36027632
[TBL] [Abstract][Full Text] [Related]
3. Pyelonephritis treatment in the community emergency department: Cephalosporins vs. first-line agents.
Vogler S; Pavich E
Am J Emerg Med; 2018 Nov; 36(11):2054-2057. PubMed ID: 30119986
[TBL] [Abstract][Full Text] [Related]
4. Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection.
Stuck AK; Täuber MG; Schabel M; Lehmann T; Suter H; Mühlemann K
Antimicrob Agents Chemother; 2012 Mar; 56(3):1359-63. PubMed ID: 22232276
[TBL] [Abstract][Full Text] [Related]
5. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
Fox MT; Melia MT; Same RG; Conley AT; Tamma PD
Am J Med; 2017 Jul; 130(7):842-845. PubMed ID: 28216442
[TBL] [Abstract][Full Text] [Related]
6. Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source.
Sutton JD; Stevens VW; Chang NN; Khader K; Timbrook TT; Spivak ES
JAMA Netw Open; 2020 Oct; 3(10):e2020166. PubMed ID: 33030555
[TBL] [Abstract][Full Text] [Related]
7. Urinary Tract Infection in Children.
Leung AKC; Wong AHC; Leung AAM; Hon KL
Recent Pat Inflamm Allergy Drug Discov; 2019; 13(1):2-18. PubMed ID: 30592257
[TBL] [Abstract][Full Text] [Related]
8. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic selection and isolate susceptibility profile in patients who failed ciprofloxacin or TMP-SMX for pyelonephritis.
Truong WR; Won KJ; Yamaki J
Am J Emerg Med; 2019 Oct; 37(10):1980-1981. PubMed ID: 31023585
[No Abstract] [Full Text] [Related]
10. National trends in emergency department antibiotic prescribing for elders with urinary tract infection, 1996-2005.
Caterino JM; Weed SG; Espinola JA; Camargo CA
Acad Emerg Med; 2009 Jun; 16(6):500-7. PubMed ID: 19245373
[TBL] [Abstract][Full Text] [Related]
11. [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].
Wagenlehner FM; Schmiemann G; Hoyme U; Fünfstück R; Hummers-Pradier E; Kaase M; Kniehl E; Selbach I; Sester U; Vahlensieck W; Watermann D; Naber KG
Urologe A; 2011 Feb; 50(2):153-69. PubMed ID: 21312083
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
[TBL] [Abstract][Full Text] [Related]
13. Urinary Tract Infection in Outpatient Children and Adolescents: Risk Analysis of Antimicrobial Resistance.
Eremenko R; Barmatz S; Lumelsky N; Colodner R; Strauss M; Alkan Y
Isr Med Assoc J; 2020 Apr; 22(4):236-240. PubMed ID: 32286027
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic therapy for acute uncomplicated pyelonephritis in women. Take resistance into account.
Prescrire Int; 2014 Dec; 23(155):296-300. PubMed ID: 25629148
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
Talan DA; Krishnadasan A; Abrahamian FM; Stamm WE; Moran GJ;
Clin Infect Dis; 2008 Nov; 47(9):1150-8. PubMed ID: 18808361
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection.
Hooton TM
Int J Antimicrob Agents; 2003 Oct; 22 Suppl 2():65-72. PubMed ID: 14527774
[TBL] [Abstract][Full Text] [Related]
17. The comeback of trimethoprim in France.
Caron F; Wehrle V; Etienne M
Med Mal Infect; 2017 Jun; 47(4):253-260. PubMed ID: 28043762
[TBL] [Abstract][Full Text] [Related]
18. Risk of antibiotic treatment failure in premenopausal women with uncomplicated urinary tract infection.
Butler AM; Durkin MJ; Keller MR; Ma Y; Dharnidharka VR; Powderly WG; Olsen MA
Pharmacoepidemiol Drug Saf; 2021 Oct; 30(10):1360-1370. PubMed ID: 33783918
[TBL] [Abstract][Full Text] [Related]
19. Association between initiation of fluoroquinolones and hospital admission or emergency department visit for suicidality: population based cohort study.
Wang J; Gagne JJ; Kattinakere-Sreedhara S; Fischer MA; Bykov K
BMJ; 2022 Oct; 379():e069931. PubMed ID: 36195324
[TBL] [Abstract][Full Text] [Related]
20. The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study.
Anesi JA; Lautenbach E; Nachamkin I; Garrigan C; Bilker WB; Omorogbe J; Dankwa L; Wheeler M; Tolomeo P; Han JH;
BMC Infect Dis; 2019 Feb; 19(1):163. PubMed ID: 30764770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]